Pharmaceuticals Archives - Healthcare Mumbai

Pharmaceuticals

USAID launches Cargill, Ausvet, Heifer International and IPC consortium to combat threat of IPC, antimicrobial resistance to human and animal health

Washington: The United States Agency for International Development (USAID) has tapped a consortium led by Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC)...

Pharmaceuticals

Skin-Deep Beauty with Microalgae Bioactive Ingredient

Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector. This topically applied bioactive ingredient from the Porphyridium...

Pharmaceuticals

RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva®, ABC294640)[1]...

Pharmaceuticals

Zentiva Continues Its Expansion In Oncology With The Launch Of ALYMSYS® (bevacizumab) In 21 Countries Across Europe

Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on...

India becoming a leading global hub for nutraceuticals post-Covid

Leading international nutraceutical companies are making a beeline for India, with India showing the potential for becoming both a large market, as also a source...

Pharmaceuticals

CPhI Discover: connecting global pharma & pre-qualifying partners ahead of in person events

Informa Markets is launching an annual dedicated online platform for pharmain May (17-28th), CPhI Discover – designed to encourage suppliers and customers to source, meet and discover –...

Pharmaceuticals

New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment

Novartis today announced new data that reinforce the transformational benefit of Zolgensma® (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular atrophy (SMA). The overall safety profile...

Pharmaceuticals

Calliditas Announces Submission of New Drug Application to U.S. FDA for Nefecon in Patients with Primary IgA Nephropathy

Calliditas Therapeutics AB (NASDAQ: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug...

Precision Oncology start-up 4baseCare raises $ 2m in pre-series A round from a consortium of venture capital firms

4baseCare, an Illumina Accelerator backed precision oncology start-up, has raised an investment of USD 2M, led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In...

Pharmaceuticals

Arjuna’s Turmeric Extract-Essential Oil Combo Demonstrates Neuroprotective Potential

A new study reveals a neuroprotective effect of curcumin extract in combination with its essential oil, suggesting a nutraceutical solution for mitigating the toxic effects...